NMC

NEA Management Company Portfolio holdings

AUM $1.33B
1-Year Return 85.82%
This Quarter Return
-18.14%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$3.46B
AUM Growth
-$1.49B
Cap. Flow
-$36.7B
Cap. Flow %
-1,058.83%
Top 10 Hldgs %
72.55%
Holding
60
New
2
Increased
6
Reduced
7
Closed
3

Top Buys

1
ACLX icon
Arcellx
ACLX
$72.2M
2
GLBE icon
Global E Online
GLBE
$13.3M
3
AUPH icon
Aurinia Pharmaceuticals
AUPH
$11.1M
4
GERN icon
Geron
GERN
$3.89M
5
RGLS
Regulus Therapeutics
RGLS
$2.38M

Top Sells

1
TRVI icon
Trevi Therapeutics
TRVI
$36.4B
2
HOOD icon
Robinhood
HOOD
$322M
3
CSPR
Casper Sleep Inc.
CSPR
$41.6M
4
ANNX icon
Annexon
ANNX
$10.4M
5
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
$1.97M

Sector Composition

1 Healthcare 52.93%
2 Technology 19.42%
3 Financials 18.96%
4 Industrials 5.25%
5 Communication Services 2.1%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AKUS
26
DELISTED
Akouos, Inc. Common Stock
AKUS
$20.4M 0.59%
4,298,488
– –
VTGN icon
27
VistaGen Therapeutics
VTGN
$112M
$20.2M 0.58%
543,420
– –
AFMD
28
DELISTED
Affimed
AFMD
$19.3M 0.56%
442,649
– –
TRVI icon
29
Trevi Therapeutics
TRVI
$866M
$17.1M 0.5%
2,798
-5,937,998
-100% -$36.4B
IVA
30
Inventiva
IVA
$745M
$14.9M 0.43%
1,298,700
– –
BILL icon
31
BILL Holdings
BILL
$4.67B
$14.2M 0.41%
66,100
+30
+0% +$6.46K
CVRX icon
32
CVRx
CVRX
$201M
$14.2M 0.41%
2,370,858
– –
OKUR
33
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$35.3M
$14.1M 0.41%
478,692
– –
CSBR icon
34
Champions Oncology
CSBR
$94.7M
$13.9M 0.4%
1,713,720
– –
GLBE icon
35
Global E Online
GLBE
$5.85B
$13.3M 0.38%
+436,282
New +$13.3M
GNCA
36
DELISTED
Genocea Biosciences, Inc.
GNCA
$13M 0.37%
10,376,936
– –
MILE
37
DELISTED
Metromile, Inc. Common Stock
MILE
$12.4M 0.36%
9,384,285
– –
ALLK
38
DELISTED
Allakos
ALLK
$12.3M 0.36%
2,164,704
– –
STSA
39
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$11.9M 0.35%
3,142,958
– –
CBIO
40
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$10.4M 0.3%
90,890
– –
SYBX icon
41
Synlogic
SYBX
$17.1M
$10.2M 0.29%
281,961
– –
INZY
42
DELISTED
Inozyme Pharma
INZY
$10M 0.29%
2,444,379
– –
BDTX icon
43
Black Diamond Therapeutics
BDTX
$160M
$9.56M 0.28%
3,449,845
– –
PHAS
44
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$8.77M 0.25%
6,643,702
-2
-0% -$3
XERS icon
45
Xeris Biopharma Holdings
XERS
$1.27B
$8.31M 0.24%
3,246,785
-3,215
-0.1% -$8.23K
OBSV
46
DELISTED
ObsEva SA Ordinary Shares
OBSV
$6.93M 0.2%
4,586,563
– –
ELVN icon
47
Enliven Therapeutics
ELVN
$1.21B
$6.22M 0.18%
827,023
-69,570
-8% -$523K
MEIP icon
48
MEI Pharma
MEIP
$138M
$5.14M 0.15%
426,654
– –
LXRX icon
49
Lexicon Pharmaceuticals
LXRX
$374M
$4.98M 0.14%
2,382,286
– –
MRKR icon
50
Marker Therapeutics
MRKR
$11.3M
$4.71M 0.14%
1,071,429
– –
1
2
3